Ryan Gosling's Latest Appearance Is a 180 From His Wild Sci‑Fi Transformation
Ryan Gosling is ditching his wild beard and long locks from the sci-fi transformation he debuted earlier this summer.
Over the weekend, the 44-year-old actor stopped by San Diego Comic-Con where he appeared on a panel to discuss his upcoming film, Project Hail Mary. While Gosling was on hand to discuss his on screen journey to space, he looked nothing like his character.
In the trailer, which premiered in June, Gosling was almost unrecognizable with a bushy beard and unwashed, stringy hair — and at Comic-Con, Gosling was back to his usual, well-kept self.
He was joined by the film's directors Phil Lord and Christopher Miller as well as screenwriter Drew Goddard and author Andy Weir, who penned The Martian, the novel that inspired the film.
🎬 SIGN UP for Parade's Daily newsletter to get the latest pop culture news & celebrity interviews delivered right to your inbox 🎬
The movie is set to follow middle school teacher Ryland Grace who is tasked with traveling to space, 11.9 light-years away, in order to figure out why the sun is dying and save Earth from extinction.
In the midst of his endeavor, Grace wakes up on a spaceship, confused about why he is there and lacking any recollection of his past. Although the teacher attempts to bow out of the massive responsibility, he quickly learns that he doesn't have a choice in the matter.
While discussing his physical transformation for the role at the event, Gosling jokingly referred to his character as "a space caveman, in this placenta onesie" — noting that he hopes to see the placenta onesie at Comic-Con in the future.
Gosling added that he and the writers "tried to create these different layers to him as he's evolving from a space caveman to a space person that needs to do some really important stuff."
"What's so inspiring about him is he reacts to a lot of things like I might or a lot of us might, and he's terrified appropriately of the task at hand," Gosling said, per PEOPLE. "He's somebody who on Earth had given up on himself, and has been given this opportunity to believe in himself again."
Project Hail Mary is set to premiere March 20, 2026.
Watch the Project Hail Mary trailer below.
Ryan Gosling's Latest Appearance Is a 180 From His Wild Sci‑Fi Transformation first appeared on Parade on Jul 27, 2025
This story was originally reported by Parade on Jul 27, 2025, where it first appeared.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Digital Trends
a minute ago
- Digital Trends
Remember Ingenuity? NASA's proposed Skyfall mission takes it further in stunning video
NASA's incredible Ingenuity helicopter spent nearly three flying across the surface of Mars, becoming the first aircraft to achieve powered, controlled flight on a planet other than Earth. After suffering damage to one of its blades in early 2024, Ingenuity was grounded for good, and now rests on the martian surface as a testament to technological innovation and the triumph of autonomous flight on another planet. In an exciting development, the plucky helicopter has now inspired Skyfall, a mission concept recently unveiled by Virginia-based AeroVironment (AV) and NASA's Jet Propulsion Laboratory (JPL), who worked together to develop the Ingenuity aircraft. As you can see in the video at the top of this page, the Skyfall mission is designed to deploy not one but six helicopters on Mars, each of which would fly off to explore various locations selected by NASA as potential landing spots for the first crewed mission to the red planet, which could take place in the 2030s. The gathered data could also help scientists learn more about Mars, contributing to the expanding database of information collected by other Mars vehicles such as the Perseverance and Curiosity rovers. The video shows the dramatic Skyfall Maneuver, described by AV as 'an innovative entry, descent, and landing technique whereby the six rotorcraft deploy from their entry capsule during its descent through the martian atmosphere.' With the helicopters flying down to the Mars surface under their own power, the Skyfall system would do away with the need for a landing platform, which is one of the most expensive parts of any Mars mission and also carries huge risk. Just like Ingenuity, each helicopter would be capable of operating autonomously, and beam high-resolution imagery back to Earth for analysis, allowing mission planners to select the best possible landing location for the first human mission. 'Skyfall offers a revolutionary new approach to Mars exploration that is faster and more affordable than anything that's come before it,' said William Pomerantz, head of space ventures at AV. 'Thanks to a true partnership between industry and government, we're expanding the unprecedented success of Ingenuity.' Pomerantz added that with six helicopters, 'Skyfall offers a low-cost solution that multiplies the range we would cover, the data we would collect, and the scientific research we would conduct, making humanity's first footprints on Mars meaningfully closer.' With NASA's first human missions in mind and the need to identify an ideal landing area, AV is already working with NASA's JPL in the hope of getting the green light for the mission before working toward a potential 2028 launch.
Medscape
a minute ago
- Medscape
Claims Data Fail to Accurately Identify MI Types
TOPLINE: Clinical auditing reveals significant misclassification in administrative codes for myocardial infarction (MI), with only 39% of type 1 (T1MI) codes and 72% of type 2 (T2MI) codes for the condition accurately reflecting the true diagnosis, researchers found. Nearly half of patients coded for T1MI had T2MI, whereas 26% of T2MI codes represented myocardial injury. METHODOLOGY: Researchers identified 350 randomly sampled patients with T1MI codes and 350 patients with T2MI codes during inpatient encounters using the International Statistical Classification of Diseases and Related Health Problems-10th Revision. The analysis included patients aged 65 years and older from October 1, 2017, to May 9, 2024, within eight hospitals in the Mass General Brigham system. Using the 4th Universal Definition of MI, the researchers reviewed the clinical encounters to assess evidence of plaque erosion or thrombus vs oxygen demand-supply imbalance. A second physician review was conducted for 146 challenging and 146 nonchallenging cases. TAKEAWAY: Among the 350 patients coded as having had T1MI, clinical adjudication revealed 138 (39%) as correctly diagnosed; 159 (45%) in fact had T2MI, and 35 (10%) had myocardial injury. Of the 350 patients coded as having had T2MI, 251 (72%) were confirmed, four (1%) were found to have T1MI, and 91 (26%) had myocardial injury. A second physician review demonstrated a high degree of agreement with the initial review, with a 94% agreement in nonchallenging cases and 86% in challenging cases. Hospitals equipped with vs without cardiac catheterization laboratories showed significantly lower misclassification rates (43% vs 58%; P = .0298). IN PRACTICE: 'Among individuals assigned a T1MI claims code, nearly one half have T2MI and many others have myocardial injury; fewer than one half have true T1MI,' the researchers reported. 'Our results also confirm and extend previous work showing that among those with T2MI codes, slightly more than one half have true T2MI, with most of the misclassification related to myocardial injury rather than T1MI. This has critically important implications for epidemiology and public policy' related to acute myocardial infarction. SOURCE: The study was led by Andrea Martinez, MD, of the Department of Medicine at Massachusetts General Hospital, Boston. It was published online on July 21 in Journal of the American College of Cardiology. LIMITATIONS: The results may not be generalized to other hospital systems and countries, where patterns of misclassification might differ. The researchers noted external validity assessment across multiple healthcare systems and in countries that have already introduced International Classification of Diseases-11th revision coding would be beneficial. While patterns of misclassification might have changed over time, the analysis was intentionally restricted to the period when codes for both T1MI and T2MI were available. DISCLOSURES: The study received support through a grant to Jason Wasfy from the Massachusetts General Hospital Executive Committee on Research. Individual authors reported receiving other grants and support, including grants from industry. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
30 minutes ago
- Yahoo
Horror's middle class is vanishing – and that's bad news for all film fans
Does no one want to watch people get butchered any more? Horror, long recognised as one of Hollywood's most reliable cash cows, is in a panic: few scary movies are breaking through financially in 2025, many more are cratering completely, and questions are being asked about the future of a genre that once seemed as durable as Jason Voorhees. Forget the death of the archetypal movie star: if sassy psycho-cyborg M3GAN can't open a movie, who can? Back in 2022, the first M3GAN – about an artificially intelligent doll with a bloodthirst – grossed $182m (£135m), including $78m of pure profit for its backers at Universal Pictures and the micro-budget horror studio Blumhouse, off a production budget of just $12m. Thanks to smart marketing, which turned its leading lady's incongruous dancefloor skills into a spooky meme, M3GAN ended up exemplifying the dream outcome of the modern studio horror film: low-cost, big-brain thrills with such inescapable dazzle that audiences couldn't not seek it out. Why, then, did last month's M3GAN 2.0 go so badly? In four weeks, the more action-oriented sequel has grossed a measly $38m worldwide, a result so mortifying that the head of Blumhouse put his hands up within days of its release and admitted to having totally missed the mark. M3GAN 2.0 isn't alone, either. This year has seen a staggering number of horror films die at the box office, among them Blumhouse's reboot of Wolf Man ($34m gross on a production budget of $20m), the Ayo Edebiri horror comedy Opus ($2m gross/$10m budget), Jenna Ortega vehicle Death of a Unicorn ($16m gross/$15m budget), the well-received adoption chiller Bring Her Back ($23m gross/$15m budget), and last week's revival of the Nineties hit I Know What You Did Last Summer, which opened to a flat $13m in the US. Yes, these films' production budgets are lean (though the extent of marketing budgets is largely kept under lock and key), and many of the above titles will ultimately break even once video-on-demand grosses are factored in – but none of their respective backers will be happy with what amounts to loose change. On the other end of the spectrum, meanwhile, are this year's handful of out-and-out horror smashes, most significantly the Michael B Jordan vampire film Sinners, which cost a reported $100m to make but has grossed $365m. There's also been Final Destination: Bloodlines ($285m and counting on a budget of $50m) and Danny Boyle's 28 Years Later, which has so far grossed $145m on a budget of $60m – not wildly profitable, by any means, but decent enough. So people are still going to see horror on the big screen, but – echoing the Western world as a whole – horror's middle class is evaporating. The genre seems to either go big or collapse entirely. Any kind of financial in-between is rapidly becoming a thing of the past. All this leaves a film such as next week's Weapons carrying undue levels of pressure. A missing-persons thriller starring Julia Garner and Josh Brolin, it revolves around the disappearance of a class of children in small-town USA, and serves as filmmaker Zach Cregger's follow-up to his 2022 sleeper hit Barbarian. Promotion for the film has been strong – lots of abstract and eerie imagery in trailers, and attempts at virality via the publishing of two hours of 'surveillance footage' from the night of the children's 'disappearance'. But the stakes feel particularly high. Weapons sparked a bidding war between rival studios when Cregger first unveiled his script, with Warner Bros so eager to get the up-and-comer on side that they coughed up a $38m budget for the film, and allowed him final cut. If Weapons underperforms, this kind of investment in a young, ambitious filmmaker's original ideas may become even rarer than it is already. Why this is bad for everyone is that, in the last decade or so, horror has been one of the few genres to wholeheartedly embrace fresh ideas and fresh voices. The likes of Jordan Peele's Get Out (2017), Coralie Fargeat's The Substance (2024), Ari Aster's Hereditary (2018) and Robert Eggers's The Witch (2015) proved that audiences will turn out in droves for intriguing new concepts, no matter how wild they might seem on paper – and in the process, an entire generation of buzzy new filmmakers developed fanbases, industry clout, and (relative) name recognition. Speaking to The Town podcast shortly after M3GAN 2.0 bombed, Blumhouse head Jason Blum suggested that there is simply too much horror being released for many films to break through, and that the cheap-to-produce movies that were Blumhouse's bread and butter (their biggest hits have included Get Out, Us, The Invisible Man and the Purge franchise) no longer cut it. 'We need to up the budgets,' he insisted. 'People need theatrical events.' Which is, I suppose, accurate. This year's most successful horror films had heavy promotional spends behind them, while even the most financially lucrative horrors of 2024 – meaning the low-cost, high-return likes of The Substance and Oz Perkins's Silence of the Lambs pastiche Longlegs – were transformed into must-see 'events' via relentless and effective marketing. But just as important is the actual quality of material on offer, with far too many modern horror movies settling for tedious mining of intellectual property and repetitive premises (Knives Out and Midsommar have created an unfortunate cottage industry of star-studded, eat-the-rich, religious-cult disappointments). Blumhouse have been particularly guilty of this over the last 18 months, tossing out a raft of movies that felt as if they were formed backwards from an already unimpressive elevator pitch: Night Swim (haunted pool!); AfrAId (haunted Alexa device!); House of Spoils (Ariana DeBose!). Things may, however, be looking up. As much as it pains me to slander a film that made smart use of Nineties stalwarts Freddie Prinze Jr and Jennifer Love Hewitt, it is something of a relief that I Know What You Did Last Summer couldn't get people in cinema seats last week. A largely serviceable but poorly directed slasher pastiche, the film may have lifted the story beats and faces from the 1997 original, but it failed at the things that truly matter: character development, suspense, memorable chase sequences. It seemed to prove that, when it comes to horror, box-office success in 2025 requires far more than just dusting off some old IP and hoping for the best. Hollywood does have a knack for taking all the wrong lessons from its success stories. (Just look at how Barbie's gargantuan box office has led to the development of loads of other movies about toys.) But wouldn't it be lovely if the triumph of Sinners sparked an influx of expensive, original horror movies moving forward – and not, well, Sinners 2. 'Weapons' is released 8 August
